Articles published by MarketBeat
Cullinan Therapeutics Eyes December Data Catalyst for CLN-978 and CLN-049 ↗
September 28, 2026
Oportun Financial Eyes Stronger 2026 as Credit Quality, Profits Improve ↗
September 28, 2026
Tullow Oil H1 Earnings Call Highlights ↗
September 28, 2026
Cue Biopharma’s CUE-221 Hits Phase II Goals, Shows Durable CSU Response ↗
September 28, 2026
HighPeak Energy Targets Stable Output, Lower Costs and Debt Reduction ↗
September 28, 2026
Tennant Targets $250M in Robotics Sales as ERP Recovery Gains Traction ↗
September 27, 2026
Equillium Eyes Q4 Phase I Start for Ulcerative Colitis Drug EQ504 ↗
September 27, 2026
Tamboran Resources Q4 Earnings Call Highlights ↗
September 27, 2026
ThredUp Posts Record Q2, Navigates More Price-Sensitive Shoppers ↗
September 27, 2026
Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance ↗
September 27, 2026
PRA Group Highlights Strong NPL Supply, Cost Cuts and $150M Buyback Plan ↗
September 27, 2026
Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes ↗
September 27, 2026
2 Cybersecurity Stocks Breaking Out as AI Continues to Be a Tailwind ↗
September 27, 2026
3 More AI Infrastructure Plays Beyond the Big Names ↗
September 27, 2026
Commerzbank CEO Says UniCredit Approval Could Come by Early Next Year ↗
September 27, 2026
CAVA Stock Slips: Sector Fear or Valuation Reality? ↗
September 27, 2026
Why Equal-Weight Funds Hide A Yield Curve Catch ↗
September 27, 2026
5 Scary-Good Stocks With Strong October Catalysts and Breakout Potential ↗
September 27, 2026
BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AI ↗
September 27, 2026
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.